Further studies showed that background haplotype variation could confer enhanced risk or protection from APOL1 association with kidney disease, with the emergence of a new category of etiologies of CKD termed APOL1-Mediated Kidney Disease (AMKD) [17,18,19,20,21,22,23]. This evidence concerns the gene APOL1 and kidney disorder.